Robin Schmidt is the Chief Operating Officer at Sling Therapeutics, Inc.
Ms. Schmidt brings over 25 years’ of experience in clinical trials strategy and execution. She shares a diverse background across large pharma, biotech and CRO experience and brings expertise in varied therapeutic areas, including rare/orphan disease. Ms. Schmidt was the Former VP, Clinical Operations at Millendo Therapeutics.
Ms. Schmidt holds a BS in Biology and a MS in Nutrition from the University of Michigan.